Search Images Maps Play YouTube News Gmail Drive More »
Settings | Sign in

Botulinum toxin

Effect of detrusor botulinum toxin a injection on urothelial dysfunction in patients with chronic spinal cord injury ... - ‎Feb 2, 2016‎
The objective of this study is to investigate the changes of urothelial junction proteins, apoptosis and suburothelial inflammation after detrusor injection of botulinum toxin A (BoNT-A) in patients with spinal cord injury (SCI) and neurogenic detrusor ...

Considerations on patient-related outcomes with the use of botulinum toxins: is switching products safe?

Dove Medical Press - ‎Feb 8, 2016‎
Introduction: Botulinum toxin (BoNT) is the treatment of choice for many neurologic movement disorders, including blepharospasm, hemifacial spasm, and cervical dystonia.

United States Botulinum Toxin Industry 2015 Market Research Report by ReportBazzar (blog) - ‎Feb 6, 2016‎
The United States Botulinum Toxin Industry 2015 Market Research Report is a professional and in-depth study on the current state of the States Botulinum Toxin industry. The report provides a basic overview of the industry including definitions ...

MHRA Takes Action on LinkedIn Pharma Marketing

Regulatory Focus - ‎Feb 12, 2016‎
MHRA on Friday also announced that 10 UK clinics advertising botulinum toxin products amended their advertising to ensure prescription drugs are not advertised to the public.

Foodborne botulism cases linked to Bolognese sauce - ‎Feb 1, 2016‎
“Based on the restaurant inspection results (no temperature monitoring of stored preparations) and given the known conditions of toxin production, we can hypothesise that the botulinum toxin was produced during the sauce cooking process or storage.

Merz Neurosciences Announces Nationwide Availability of New 200-Unit Vial of Xeomin® (incobotulinumtoxinA)

Business Wire (press release) - ‎Feb 9, 2016‎
Spread of toxin effects. In some cases, the effect of botulinum toxin may affect areas of the body away from the injection site and cause symptoms of a serious condition called botulism.

Animal rights group against animal tests points to the RAT

New Europe - ‎Feb 11, 2016‎
... the LD50 (Lethal Dose 50%) in which botulinum toxin (commonly known as botox) is injected into the abdomens of mice to determine the dose that kills exactly half of the animals used - such batch testing can be replaced by a cell-based test; and the ...

Botox may reduce chronic neuropathic pain

Medical Xpress - ‎Feb 9, 2016‎
... toward significance at four weeks after the injection. "These results indicate that BTX-A may reduce intractable chronic neuropathic pain in patients with spinal cord injury," the authors write.
See realtime coverage

New Galderma Campaign Encourages Women To Love Their "Mom Genes"

PR Newswire (press release) - ‎Feb 4, 2016‎
Do not have Dysport treatment if you: are allergic to Dysport or any of its ingredients (see the end of the Medication Guide for a list of ingredients), are allergic to cow's milk protein, had an allergic reaction to any other botulinum toxin product ...

Novaquest Pharma Opportunities Fund Iii Recently increased Its Revance Therapeutics, Inc Position - ‎Feb 9, 2016‎
The Company is focused on the development, manufacturing and commercialization of botulinum toxin products for multiple aesthetic and therapeutic indications.

Price wars: It's time to say 'no'

ModernMedicine - ‎Feb 9, 2016‎
If consumers are led to think anyone can inject botulinum toxin and freezing fat deposits is not operator dependent, they are programmed to shop for a doctor on the basis of price alone, according to Dr.

Modified Ashworth scale and spasm frequency score in spinal cord injury: reliability and correlation - ‎Feb 9, 2016‎
Treatment of spasticity with botulinum toxin: A double-blind study. Ann Neurol 1990; 28: 512–515. | Article | PubMed | ISI | CAS |; Penn RD, Savoy SM, Corcos D, Latash M, Gottlieb G, Parke B et al.

Non-antimuscarinics show promise for overactive bladder

2 Minute Medicine - ‎Feb 7, 2016‎
Other studies have explored the role of physical therapy, beta agonist medications, neuromodulation, electrical or magnetic stimulation, botulinum toxin injection and complementary medicine in treatment of OAB. In the present work, the authors reviewed ...

Revance Therapeutics Inc (RVNC) EVP Curtis Ruegg Sells 1000 Shares of Stock

Intercooler Financial - ‎Feb 12, 2016‎
The Company is focused on the development, manufacturing and commercialization of botulinum toxin products for multiple aesthetic and therapeutic indications.
See realtime coverage

Party Official Says the Need to Travel to Buy Flu Medicine Is 'a Shame'

The Epoch Times - ‎Feb 9, 2016‎
The suspects were selling fake Botulinum toxin, skin whitening injections, and counterfeit anesthetics to beauty clinics. In September last year, police in Guangzhou, the capital of Guangdong Province, seized 1.54 million fake sexual-dysfunction drugs ...

Defining the minimally invasive patient

ModernMedicine - ‎Feb 3, 2016‎
There were 5.9 million documented cases of nonsurgical facial rejuvenation procedures, specifically soft tissue fillers and botulinum toxin in 2013 - and a 5,680% increase in injectables in the past 25 years. The numbers are only expected to grow. But ...
See realtime coverage

Here's Why The Viral '6-Year-Old Happy Meal' Story Is Stupid: The Myth Of The Non-Decomposing McDonald's Food ...

The Inquisitr - ‎Feb 10, 2016‎
Furthermore, there are many natural compounds which are very toxic (such as botulinum toxin, strychnine, lead acetate, asbestos, snake and spider venom, cardiac glycosides, cyanide, hexavalent chromium compounds…).

New Dosage Strength of Xeomin Launched

Monthly Prescribing Reference (registration) - ‎Feb 9, 2016‎
... is already approved for use in cervical dystonia in adults, to reduce severity of abnormal head position and neck pain in both botulinum toxin-naïve and previously treated patients; and for blepharospasm in adults previously treated with ...

Latest Analysts Reports On Revance Therapeutics Inc (RVNC)

Risers & Fallers - ‎Feb 8, 2016‎
The Company is focused on the development, manufacturing and commercialization of botulinum toxin products for multiple aesthetic and therapeutic indications.